Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 3:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 697–720 of 2,512 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sequence Clear all

Conditions: Renal Cell Carcinoma, Non-small Cell Lung Cancer, Pancreatic Adenocarcinoma, Colorectal Cancer, Ovarian Neoplasms
Interventions: RO7515629, tocilizumab; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Denver, Colorado • Nashville, Tennessee

Conditions: Allergic Reaction
Interventions: DESF, Epinephrine Injection; Drug
Lead sponsor: Aquestive Therapeutics; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Secaucus, New Jersey

Conditions: Healthy
Interventions: SP-103, ZTlido; Drug
Lead sponsor: Scilex Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Dilworth, Minnesota

Conditions: Sensitivity
Interventions: Intervention 1, Intervention 2, Intervention 3, Intervention 4 (sham); Device
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 40 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Visual Acuity
Interventions: Spectacles, ACUVUE OASYS®1-Day with HydraLuxe™ Technology; Device
Lead sponsor: Johnson & Johnson Vision Care, Inc.; Industry
Eligibility: 18 Years to 42 Years
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 3
States / cities: Jacksonville, Florida • Longwood, Florida • New York, New York

Conditions: Healthy
Interventions: PF-04634817; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Opioid Use Disorder
Interventions: Acute Stress Intervention (MAST-based), Non-Stress Intervention (NST-based); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Brain Metastases, Brain Metastases, Adult, Metastatic Brain Tumor, Metastatic Brain Cancer
Interventions: CEST-MRF; Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Gout
Interventions: RDEA3170 10 mg, RDEA3170 2.5 mg; Drug
Lead sponsor: Ardea Biosciences, Inc.; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Austin, Texas

Conditions: OIC
Interventions: TD-1211 IV [C14], TD-1211 PO [C14]; Drug
Lead sponsor: Glycyx Therapeutics; Industry
Eligibility: 18 Years to 50 Years · Male only
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Sickle Cell Disease
Interventions: GBT440; Drug
Lead sponsor: Global Blood Therapeutics; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Autism Spectrum Disorder
Interventions: Anatomical MRI Scan; Diagnostic Test
Lead sponsor: San Diego State University; Other
Eligibility: 40 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: San Diego, California

Conditions: Multiple Myeloma
Interventions: Not listed
Lead sponsor: Janssen Scientific Affairs, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 69
States / cities: Phoenix, Arizona • Fort Smith, Arkansas • Hot Springs, Arkansas + 63 more

Conditions: Head and Neck Neoplasms
Interventions: PET/MRI; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Drug-drug Interaction
Interventions: tucatinib, itraconazole, rifampin, gemfibrozil, repaglinide, tolbutamide, midazolam, digoxin; Drug
Lead sponsor: Seagen Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 116 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 2
States / cities: Daytona Beach, Florida • Dallas, Texas

Conditions: Newly Diagnosed Multiple Myeloma
Interventions: AZD0120, Daratumumab, Dexamethasone, Isatuximab, Lenalidomide, Bortezomib, Cyclophosphamide, Fludarabine; Biological · Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2034
U.S. locations: 45
States / cities: Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 37 more

Conditions: Healthy
Interventions: Relacorilant, Placebo to relacorilant, Moxifloxacin; Drug
Lead sponsor: Corcept Therapeutics; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Springfield, Missouri

Conditions: Suicide, Suicide, Attempted, Suicidal Ideation, Self Harm
Interventions: MI- Safety Plan, Texts messages, Monitoring, Portal follow-up, Booster call; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 13 Years to 17 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 3
States / cities: Ann Arbor, Michigan • Detroit, Michigan • Cincinnati, Ohio

Conditions: Pulmonary Disease, Chronic Obstructive, Asthma, Adverse Effect of Beta-adrenoreceptor Antagonists
Interventions: Metoprolol succinate ER, Carvedilol; Drug
Lead sponsor: VA Greater Los Angeles Healthcare System; Federal
Eligibility: 40 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Drug-drug Interaction
Interventions: Tucatinib, Metformin, Iohexol; Drug
Lead sponsor: Seagen Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Healthy
Interventions: Clopidogrel, Placebo, Pantoprazole; Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Mild Dementia, Aging, Cognitive Change
Interventions: Retinal Imaging, Pupillometry, Contrast Sensitivity, Neuropsychological Evaluation, APOE genotyping, blood draw, Gait Assessment, Actigraphy; Other · Diagnostic Test · Genetic
Lead sponsor: University of Rhode Island; Other
Eligibility: 55 Years to 80 Years
Enrollment: 165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 4
States / cities: Clearwater, Florida • St. Petersburg, Florida • Kingston, Rhode Island + 1 more

Conditions: Healthy Volunteers
Interventions: plazomicin, metformin; Drug
Lead sponsor: Achaogen, Inc.; Industry
Eligibility: 19 Years to 55 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Prostate Cancer
Interventions: Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI); Other
Lead sponsor: University of California, San Diego; Other
Eligibility: Male only
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Search by objective public record fields.

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome

Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects

Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults

Ocular Characteristics in Contact Lens and Spectacle Wear

A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers

Resilience Among Individuals With Opioid Use Disorder

Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

RDEA3170 Bioavailability Study

TD-1211 IV/Oral Mass Balance Study

A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects

Age-related Changes in Myeloarchitectonics Across Adulthood in Autism Spectrum Disorder

Multiple Myeloma Patient Registry

PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib

Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT

T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers

Adaptive Intervention for Adolescents Following Inpatient Psychiatric Care

Tolerability of Metoprolol-Succinate-ER and Carvedilol in COPD

A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib on Metformin

Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects

Atlas of Retinal Imaging in Alzheimer's Study

A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)